Related content

Hormone Replacement Therapy and Cardiovascular Risk

By Chong A-Y.   Lip G.Y.H.  

Treatments in Endocrinology, Vol. 1, Iss. 2, 2002-02 ,pp. : 95-103

Adis International

Access to resources Recommend Favorite

Sex hormones, vascular function and the outcome of hormone replacement therapy in cardiovascular disease

By Khalil Raouf A  

Future Cardiology, Vol. 3, Iss. 3, 2007-05 ,pp. : 283-300

Future Medicine

Access to resources Recommend Favorite

Effects of hormone replacement therapy on ambulatory blood pressure and vascular responses in normotensive women

By MANWARING PAUL   MORFIS LITSA   DIAMOND TERENCE   HOWES LAURENCE G.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 22-27

Informa Healthcare

Access to resources Recommend Favorite

Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A₁, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women

By Christodoulakos GE   Lambrinoudaki IV   Panoulis CP   Papadias CA   Kouskouni EE   Creatsas GC  

Gynecological Endocrinology, Vol. 18, Iss. 5, 2004-05 ,pp. : 244-257

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis

By Dane Cem   Dane Banu   Cetin Ahmet   Erginbas Murat  

Gynecological Endocrinology, Vol. 23, Iss. 7, 2007-07 ,pp. : 398-403

Informa Healthcare

Access to resources Recommend Favorite